BioStem Technologies, Inc. (BSEM)
5.115
-0.08
(-1.63%)
USD |
OTCM |
Apr 10, 12:13
BioStem Technologies EPS Diluted (Quarterly) : -0.67 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.03 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
| Travere Therapeutics, Inc. | -0.2435 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.26M |
| Revenue (Quarterly) | 10.08M |
| Total Expenses (Quarterly) | 21.34M |
| Enterprise Value | 61.28M |
| Gross Profit Margin (Quarterly) | 96.56% |
| Profit Margin (Quarterly) | -111.7% |
| Earnings Yield | -9.65% |
| Normalized Earnings Yield | -9.649 |